This $2.6B biotech stock is flashing a new uptrend — we’re buying. ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏
Biotech Breakout Alert
As I worked through my charts this weekend, one group stood out more than anything else: Biotech.
In a market full of noise and choppy price action, this is exactly what I’m looking for — pockets of strength. And this group has it.
On a relative basis, Biotech $XBI is completing a multi-year rounding bottom versus the broader market and already pushing to new highs.
|
To me, that’s what a brand new uptrend in leadership looks like.
Now the absolute trend is starting to line up as well.
XBI is coiling just below a key resistance level around 132 — right at the 61.8% Fibonacci retracement.
|
A breakout above that area would likely mark the start of a new leg higher, with 175 as a logical upside target.
The relative trend has already broken out. Now it’s the absolute trend’s turn to catch up.
When it comes to exposure in this group, a lot of investors stick with the ETF — and that works. Everyone has different goals, timeframes, and risk tolerance.
For me, I take it a step further and focus on the individual names showing the strongest setups within the sector. That’s where I want to be positioned.
Today, we’re buying a $2.6B biotech through our Minor Leaguers report — a biweekly scan focused on finding the best small-cap opportunities.
Want the full trade details and access to every small-cap setup we’re tracking this week? you can join us risk-free today.
Stay sharp 😉
Alfonso De Pablos, CMT
Director of Research, All Star Charts
|
Alfonso De Pablos, CMT | Director of Research, All Star Charts
|
|
|
All Star Charts emails are a financial publication of general circulation and only offers impersonal advice, not tailored to individual needs of a specific client or group. Any comments or statements made herein do not necessarily reflect those of All Star Charts or its affiliates (collectively, "All Star Charts") and do not constitute buy or sell recommendations. Unless specifically indicated, this message is not an official confirmation of any transaction. The contents of any email communications to or from All Star Charts may be monitored or reviewed at All Star Charts's discretion. All Star Charts accepts no responsibility for any loss or damage arising in any way from the use of this transmission and any attachments; it is the responsibility of the recipient to ensure that they are virus free. If you reply to this email, please note that we are a public investor and do not want any material non-public information. We do not agree to keep confidential any information you provide and do not agree to any restrictions on our trading activity, except pursuant to a written confidentiality agreement executed by All Star Charts.
|
Want to change how you receive these emails? You can manage your preferences here unsubscribe.
© 2026 All Star Charts 624 Broadway, Suite 405 San Diego, CA 92101
|
All Star Charts
624 Broadway
Suite 405
San Diego, CA 92101
|
|
|
|